drugset
drugset / Trial / NCT05978089

Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）

NCT05978089 ↗

Phase 4 Unknown 120 enrolled Dongzhimen Hospital, Beijing
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study adopted a randomized, double-blind, placebo-controlled, multicenter clinical design and compared the effects of Yangxinshi tablet and placebo on exercise tolerance in patients with chronic coronary syndrome (CCS).

Timeline

Start
2023-11-08
Primary completion
2025-06
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Yangxinshi Traditional medicine (herbal / TCM) 3 unknown —

Indications

coronary artery disorder